Mutations involving the KEAP1/Nrf2/Cul3 genes have been reported in 23% of lung adenocarcinomas (LUADs) [59] and 34% of lung squamous carcinomas (LUSCs) [60]. Here, KEAP1 is linked to lung adenocarcinoma.